Federated Hermes, Inc. Sesen Bio, Inc. Transaction History

Federated Hermes, Inc.

  • $43.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.73 - $1.28 $232,789 - $408,179
-318,890 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$0.77 - $4.91 $192,831 - $1.23 Million
250,430 Added 365.8%
318,890 $253,000
Q2 2021

Aug 16, 2021
BUY
$2.18 - $4.66 $149,242 - $319,023
68,460 New
68,460 $316,000
Q3 2018

Nov 13, 2018
SELL
$1.54 - $2.38 $1,683 - $2,601
-1,093 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$1.04 - $3.29 $1,136 - $3,595
1,093 New
1,093 $2,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email